That is an incredibly promising announcement. And they've reached out to FDA consultants who have suggested if the next trial is successful, it will meet the FDA emergency-use criteria. HUGE! GLTAH.
Ann: Positive Results from IHL-675 (ARDS) animal study, page-9
Add to My Watchlist
What is My Watchlist?